Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of IL18R1 protein | affects expression | 20106945
|
D001151 |
Arsenic |
[Arsenic co-treated with Fluorides] results in decreased expression of IL18R1 mRNA | affects cotreatment|decreases expression | 19962721
|
D001151 |
Arsenic |
Arsenic results in decreased expression of IL18R1 mRNA | decreases expression | 19962721
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of IL18R1 mRNA | decreases expression | 20106945
|
D000001 |
Calcimycin |
[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL18R1 protein | affects cotreatment|increases expression | 14994387
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of IL18R1 mRNA | increases expression | 20106945
|
D016264 |
Dextran Sulfate |
IL18R1 protein affects the susceptibility to Dextran Sulfate | affects response to substance | 12940437
|
D004137 |
Dinitrochlorobenzene |
Dinitrochlorobenzene results in increased expression of IL18R1 mRNA | increases expression | 11708898
|
D005459 |
Fluorides |
[Arsenic co-treated with Fluorides] results in decreased expression of IL18R1 mRNA | affects cotreatment|decreases expression | 19962721
|
D005459 |
Fluorides |
Fluorides results in decreased expression of IL18R1 mRNA | decreases expression | 19962721
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of IL18R1 mRNA | affects binding|increases activity|increases expression | 19710929
|
D013755 |
Tetradecanoylphorbol Acetate |
[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL18R1 protein | affects cotreatment|increases expression | 14994387
|
C024746 |
tobacco tar |
tobacco tar results in decreased expression of IL18R1 mRNA | decreases expression | 19559774
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.27 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.01 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.73 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.67 | 16434500 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.43 | 17306315 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.25 | 19183758 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.90 | 16835338 12569548 16251483 18414634 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.33 | 12928151 19371607 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.29 | 19483382 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.02 | 20146248 17474063 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.66 | 15504454 17687452 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
3.28 | 12907637 21507988 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
3.28 | 17306315 16507464 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
7.86 | 18922899 17687452 15504454 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.86 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
7.86 | 18922899 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.21 | 18640142 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.54 | 15738583 17938729 19152805 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.43 | 16973168 18022660 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.32 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
tobacco tar |
7.32 | 19559774 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.10 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.10 | 19176532 |
MESH:D003092 |
Colitis |
|
Dextran Sulfate |
5.78 | 16375993 15652231 12065299 18023891 |
MESH:D003093 |
Colitis, Ulcerative |
|
Dinitrochlorobenzene |
3.89 | 17373747 19159591 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dinitrochlorobenzene |
4.37 | 15491423 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.48 | 18249437 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.46 | 12083418 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
7.46 | 8113982 16716910 7812673 11698051 8273558 15177302 9599246 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.04 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.03 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.03 | 19236843 20131406 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.32 | 12639820 12168785 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.78 | 6392382 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.41 | 8708960 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.72 | 20471113 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.62 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.62 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.17 | 16221962 19772884 19176532 18467677 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.31 | 20558911 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.59 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
5.46 | 16076760 11953799 9931084 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.46 | 10903974 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.78 | 16093927 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
3.15 | 11698051 8273558 7562506 7812673 15177302 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Dextran Sulfate |
4.69 | 15339030 20423518 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.72 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.66 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.18 | 12749816 16930632 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.41 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.85 | 12371664 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
3.64 | 17339181 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.34 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.57 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
11.12 | 9163691 15890375 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
11.12 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
11.12 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
11.12 | 20007298 16377806 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
2.82 | 8603461 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
5.03 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
5.03 | 17306315 19168569 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
5.03 | 18520028 20869020 17053015 20064080 18569708 6695378 20464547 18816296 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
5.03 | 11807781 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
3.44 | 8985016 |
MESH:D008545 |
Melanoma |
|
Dinitrochlorobenzene |
3.21 | 12202904 17334785 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.01 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.30 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.68 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.19 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
4.09 | 15371236 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.05 | 16411023 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.03 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.03 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.66 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.41 | 19348381 18481113 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
3.54 | 16620997 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.52 | 17056641 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
2.78 | 17306315 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
3.17 | 15976015 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
4.47 | 12065085 18404319 8330346 18922899 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.34 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.18 | 16905509 6392382 15371236 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.35 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
3.27 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.27 | 17292933 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
4.15 | 21343184 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.27 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.45 | 19058328 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.78 | 17453740 19834688 16759981 15952646 17548696 17938729 16702368 6392382 17050553 18709164 16353154 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
9.96 | 17976673 19538983 17029826 17050553 15504454 16251483 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.96 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
9.96 | 18404319 11807781 8330346 12065085 8985016 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
5.33 | 19322015 19429237 11144890 15987713 17976673 18640142 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.33 | 17053015 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.20 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.93 | 17056641 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.66 | 17120751 |